<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01601652</url>
  </required_header>
  <id_info>
    <org_study_id>225576</org_study_id>
    <secondary_id>UCD#225576-3</secondary_id>
    <nct_id>NCT01601652</nct_id>
  </id_info>
  <brief_title>Compassionate Use of an Intravenous Fish Oil Emulsion in Infants With Cholestasis</brief_title>
  <official_title>Open Label, Compassionate Use Protocol of an Intravenous Fish Oil Emulsion in Infants With Cholestasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arthur J De Lorimier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will evaluate the safety and efficacy of an intravenous fish oil emulsion
      (omegaven) in infants with parenteral nutrition associated cholestasis.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Normalization of conjugated bilirubin (conjugated bilirubin &lt; 2 mg/dL)</measure>
    <time_frame>approximately for 4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Liver transaminases</measure>
    <time_frame>approximately for 4 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Parenteral Nutrition Associated Cholestasis</condition>
  <arm_group>
    <arm_group_label>Omeagven</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Omegaven</intervention_name>
    <description>1 g/kg/d iv infusion over 24h</description>
    <arm_group_label>Omeagven</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Cholestasis defined as either

          -  serum bilirubin &gt; 2mg/dL (two measurements at least 8d apart) that has not responded
             to 4 weeks of intralipid being reduced to 1 g/kg/d and trace minerals being limited to
             twice weekly, OR

          -  serum bilirubin &gt; 6 mg/dL (single measurement) and rising, in the absence of proven or
             suspected sepsis

        Exclusion Criteria:

          -  Age &gt; 1y at time that omegaven is started

          -  Not expected to survive at least 30 days

          -  Fish allergy in a first degree relative

          -  Hemodynamic instability

          -  Coagulopathy

          -  Not likely to require PN for &gt; 30d

          -  Not expected to survive &gt; 30d
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Year</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ian J Griffin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UC Davis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California Davis Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2012</study_first_submitted>
  <study_first_submitted_qc>May 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 18, 2012</study_first_posted>
  <last_update_submitted>March 27, 2018</last_update_submitted>
  <last_update_submitted_qc>March 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Davis</investigator_affiliation>
    <investigator_full_name>Arthur J De Lorimier</investigator_full_name>
    <investigator_title>Associate Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>cholestasis</keyword>
  <keyword>PNAC</keyword>
  <keyword>Parenteral Nutrition Associated Cholestasis</keyword>
  <keyword>PNALD</keyword>
  <keyword>Parenteral Nutrition Associated Liver Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholestasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

